News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Integrium Appoints Michael Gleeson As Chief Executive Officer



10/19/2005 5:10:30 PM

TUSTIN, Calif.--(BUSINESS WIRE)--May 5, 2005--Integrium, a contract research organization (CRO), announced the appointment of Michael Gleeson to the position of chief executive officer, formerly held by Dr. David Smith - one of Integrium's founding partners. Smith will continue in a key role at Integrium by focusing on the company's medical affairs and pharmacovigilance services. Gleeson is responsible for further establishing Integrium as a premier CRO for biopharmaceutical and medical device companies. He will ensure the continued growth and expansion of Integrium, and will strategically position the company's operations and service offerings to meet continually changing industry needs. Gleeson brings extensive leadership, operations, and business development experience to Integrium from his 35+ years in the healthcare industry.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES